CIBC Asset Management
ARRY

CIBC Asset Management’s Array Biopharma Inc ARRY Stock Holding History

CIBC Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7,445
Closed -$345K – 1172
2019
Q2 		$345K Buy
+7,445
New +$209K ﹤0.01% 805

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

CIBC Asset Management's ARRY Position: Q3 2019 in Review

CIBC Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 7,445 shares — an estimated $345K sold.

CIBC Asset Management first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $345K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • CIBC Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • CIBC Asset Management sold 7,445 Array Biopharma Inc shares in Q3 2019, an estimated $345K.
  • CIBC Asset Management first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • CIBC Asset Management's Array Biopharma Inc position peaked at $345K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on CIBC Asset Management's 13F filing for Q3 2019, filed 30 Oct 2019.